Skip to main content

Erratum to: Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats

The Original Article was published on 25 November 2014

Erratum

In the original article [1], the following information was omitted from the funding section:

“This study was supported by a faculty research grant of Yonsei University College of Medicine for 2009 (6-2009-0101).”

Reference

  1. 1.

    Yang, et al. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats. Respir Res. 2016;15(1):148.

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Hyuk-Jae Chang.

Additional information

The online version of the original article can be found under doi:10.1186/s12931-014-0148-4.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Yang, PS., Kim, DH., Lee, Y.J. et al. Erratum to: Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats. Respir Res 17, 142 (2016). https://doi.org/10.1186/s12931-016-0458-9

Download citation